HealthMigraine Prevention Drug Receives FDA Approval: Aimovig By Amgen Is The First Of Its Kind Aimovig, designed for long-term migraine prevention, will now go on sale after receiving approval from the U.S. Food and Drug Administration. The drug is the first of its kind, and it could soon mean the end of chronic migraines.by Aaron Mamiit
HealthCurrent And Former Smokers Refuse To Get Screened For Lung Cancer, Study Claimsby Jacob Elyachar
HealthRomaine Lettuce Safe To Eat Again: Contaminated Lettuce Behind E. Coli Outbreak Now Past Shelf Lifeby Aaron Mamiit
HealthFDA Approves Lucemyra, The First Non-Opioid Drug For Opioid Withdrawal Symptoms Up To 14 Daysby Steven Lerner
Health4,000 Ebola Vaccines Arrive In The Democratic Republic Of Congo, Officials Sayby Jacob Elyachar
HealthEgg Farm That Spread Salmonella Throughout The Country Had 'Unacceptable Rodent Activity'by Jean-Pierre Chigne
HealthWHO Wants Trans Fat Out Of Food Supply: Types Of Food To Avoid To Cut Back On Trans Fatsby Manthan Chheda